Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576186 · ClinicalTrials.gov registry record
Validation of the Gated Blood Pool SPECT: ERNA vs 3D Echo
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 30
- Enrollment target
NCT00576186: Completed study, sponsored by Yale University.
NCT00576186 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00576186 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This research study is designed to evaluate the accuracy of the techniques that are used to analyze heart function. The main purpose of this study is to analyze and compare three different methods of assessment of regional and overall heart function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-02 |
| Est. Completion | 2015-11 |
What the finished NCT00576186 record still lists
NCT00576186 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00576186 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00576186 about?
NCT00576186 is a clinical study titled "Validation of the Gated Blood Pool SPECT: ERNA vs 3D Echo". This research study is designed to evaluate the accuracy of the techniques that are used to analyze heart function. The main purpose of this study is to analyze and compare three different methods of assessment of regional and overall heart function.
What is the current status of trial NCT00576186?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2005-02. Estimated completion is 2015-11.
Who is sponsoring clinical trial NCT00576186?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia